- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ANGO
Recent news which mentions ANGO
Tickers
ANGO
From Motley Fool
From Benzinga
From Benzinga
Earnings Scheduled For April 7, 2022
April 07, 2022
From Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
From Benzinga
4 Stocks Insiders Are Buying
January 13, 2022
From Benzinga
AngioDynamics Earnings Perspective: Return On Capital Employed
January 07, 2022
Tickers
ANGO
From Benzinga
Earnings Scheduled For January 6, 2022
January 06, 2022
From Benzinga
Direxion Launches New Nanotechnology ETF, TYNE
November 23, 2021
From ETF Trends
Is This Under-the-Radar Medical Devices Stock a Buy?
November 03, 2021
From Motley Fool
51 Biggest Movers From Friday
October 18, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 15, 2021
October 15, 2021
From Benzinga
10 Biggest Price Target Changes For Friday
October 15, 2021
From Benzinga
51 Biggest Movers From Yesterday
October 01, 2021
From Benzinga
Mid-Afternoon Market Update: Gold Rises 2%; Bed Bath & Beyond Shares Slide
September 30, 2021
From Benzinga
Investors Cheer AngioDynamics' Q1 Beat, Raised FY22 Sales Outlook
September 30, 2021
Tickers
ANGO
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 30, 2021
From Benzinga
From Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
September 30, 2021
From Benzinga
Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript
September 30, 2021
Tickers
ANGO
From Motley Fool
Mid-Morning Market Update: Markets Mixed; CarMax Profit Misses Views
September 30, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Earnings Scheduled For September 30, 2021
September 30, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.